Achieve Life Sciences Announces Participation at LD Micro Invitational Conference
May 26, 2022 08:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 26, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and...
Achieve Life Sciences Announces Participation at Best Ideas Virtual Investor Conference
May 13, 2022 08:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 13, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and...
Achieve Reports Financial Results for First Quarter 2022 and Provides Corporate Update
May 12, 2022 16:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 12, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and...
New Randomized-Controlled Trial Finds that Quit Genius Digital Clinic is Significantly More Effective than Traditional Standard of Care for Addiction
May 05, 2022 09:00 ET
|
Quit Genius Medical, P.C.
NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, announced today that a new study published in Nicotine &...
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 12, 2022
April 21, 2022 08:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development...
Insights on the Smoking Cessation & Nicotine De-Addiction Product Global Market to 2026 - Growing Awareness Regarding Use of E-Cigarettes Presents Opportunities
April 20, 2022 06:23 ET
|
Research and Markets
Dublin, April 20, 2022 (GLOBE NEWSWIRE) -- The "Global Smoking Cessation & Nicotine De-Addiction Product Market (2021-2026) by Product, Distribution Channel, Geography, Competitive Analysis and...
Mydecine Receives Conditional IRB Approval for Phase 2b Smoking Cessation Study
March 24, 2022 07:30 ET
|
Mydecine Innovations Group Inc.
DENVER, March 24, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), a biotechnology company aiming to transform the...
Achieve Life Sciences Announces Cytisinicline Presentation at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
March 15, 2022 08:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, March 15, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development...
Achieve Life Sciences Announces Appointment of Dr. Vaughn Himes to Board of Directors
March 14, 2022 08:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, March 14, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development...
Achieve Life Sciences Announces Expansion of Manufacturing & Quality Operations Team and Granting of Inducement Award
March 11, 2022 08:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, March 11, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development...